A role for urokinase-type plasminogen activator in human immunodeficiency virus type 1 infection of macrophages

Journal of Virology

Volumn 70, Issue 7, 1996, Pages 4451-4456

  Handley, Mark A ^a,b   Steigbigel, Roy T ^a   Morrison, Sidonie A ^a  

^a STONY BROOK UNIVERSITY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WISCONSIN MADISON   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN P24; CD4 ANTIGEN; GLYCOPROTEIN GP 120; HEPARIN; NEUTRALIZING ANTIBODY; PLASMINOGEN ACTIVATOR INHIBITOR; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; UROKINASE;

ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; MACROPHAGE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN DEGRADATION; VIRUS CELL INTERACTION; VIRUS REPLICATION;

EID: 0030011633     PISSN: 0022538X     EISSN: None     Source Type: Journal    
DOI: 10.1128/jvi.70.7.4451-4456.1996     Document Type: Article

References (47)

1. Andersen, K. B., and H. Skov. 1989. Retrovirus-induced cell fusion is enhanced by protease treatment. J. Gen. Virol. 70:1921-1927.
2. 1-antitrypsin variant. J. Biol. Chem. 268:24887-24891.
3. Avril, L. E., M. Di Martino-Ferrer, G. Pignede, M. Séman, and F. Gauthier. 1994. Identification of the U-937 membrane-associated proteinase interacting with the V3 loop of HIV-1 gp120 as cathepsin G. FEBS Lett. 345:81-86.
4. Berger, E. A., J. R. Sister, and P. L. Earl. 1992. Human immunodeficiency virus type 1 envelope protein glycoprotein molecules containing membrane fusion-impairing mutations in the V3 region efficiently undergo soluble CD4-stimulated gp120 release. J. Virol. 66:6208-6212.
5. Böyum, A. 1968. Isolation of mononuclear cells and granulocytes from human blood. Isolation of mononuclear cells by one centrifugation, and of granulocytes by combining centrifugation and sedimentation at 1 g. Scand. J. Lab. Clin. Invest. Suppl. 97:77-89.
6. Cheng-Mayer, C., and J. A. Levy. 1988. Distinct biological and serological properties of human immunodeficiency viruses from the brain. Ann. Neurol. 23:S58-S61.
7. Clements, G. J., M. L. Price-Jones, P. E. Stephens, C. Sutton, T. F. Schulz, P. R. Clapham, J. A. McKeating, M. O. McClure, S. Thomson, M. Marsh, J. Kay, R. A. Weiss, and J. P. Moore. 1991. The V3 loops of the HIV-1 and HIV-2 surface glycoproteins contain proteolytic cleavage sites: a possible function in viral fusion. AIDS Res. Hum. Retroviruses 7:3-16.
8. Decroly, E., M. Vandenbranden, J. M. Ruysschaert, J. Cogniaux, G. S. Jacob, S. C. Howard, G. Marshall, A. Kompelli, A. Basak, F. Jean, C. Lazure, S. Benjannet, M. Chrétien, R. Day, and N. G. Seidah. 1994. The convertases furin and PC1 can both cleave the human immunodeficiency virus (HIV)-1 envelope glycoprotein gp160 into gp120 (HIV-1 SU) and gp41 (HIV-1 TM). J. Biol. Chem. 269:12240-12247.
9. Durda, P. J., L. Bacheler, P. Clapham, A. M. Jenoski, B. Leece, T. J. Matthews, A. McKnight, R. Pomerantz, M. Rayner, and K. J. Weinhold. 1990. HIV-1 neutralizing monoclonal antibodies induced by a synthetic peptide. AIDS Res. Hum. Retroviruses 6:1115-1123.
10. Ellis, V., N. Behrendt, and K. Danø. 1991. Plasminogen activation by receptor-bound urokinase: a kinetic study with both cell-associated and isolated receptor. J. Biol. Chem. 266:12752-12758.
11. Freed, E. O., E. L. Delwart, G. L. Buchschacher, and A. T. Panganiban. 1992. A mutation in the human immunodeficiency virus type 1 transmembrane glycoprotein gp41 dominantly interferes with fusion and infectivity. Proc. Natl. Acad. Sci. USA 89:70-74.
12. Freed, E. O., D. J. Myers, and R. Risser. 1991. Identification of the principal neutralizing determinant of human immunodeficiency virus type 1 as a fusion domain. J. Virol. 65:190-194.
13. Ghiara, J. B., E. A. Stura, R. L. Stanfield, A. T. Profy, and I. A. Wilson. 1994. Crystal structure of the principal neutralization site of HIV-1. Science 264:82-85.
14. Hamilton, J. A., G. Vairo, K. R. Knight, and B. G. Cocks. 1991. Activation and proliferation signals in murine macrophages. Biochemical signals controlling the regulation of macrophage urokinase-type plasminogen activator by colony-stimulating factors and other agents. Blood 77:616-627.
15. Handley, M. A., S. A. Morrison, and R. T. Steigbigel. 1992. Human immunodeficiency virus infection of macrophages induces secretion of protease. Clin. Res. 40:355A. (Abstract.)
16. Handley, M. A., R. T. Steigbigel, and S. A. Morrison. 1994. Urokinase (uPA) cleaves gp120 of HIV-1 and promotes viral infectivitv. Clin. Res. 42:155A. (Abstract.)
17. Harvima, I. T., R. J. Harvima, G. Nilsson, L. Ivanoff, and L. B. Schwartz. 1993. Separation and partial characterization of proteinases with substrate specificity for basic amino acids from MOLT-4 T lymphocytes: identification of those inhibited by variable-loop-V3 peptides of HIV-1 envelope glycoprotein. Biochem. J. 292:711-718.
18. Hattori, T., A. Koito, K. Takatsuki, H. Kido, and N. Katunuma. 1989. Involvement of tryptase-related cellular protease(s) in human immunodeficiency virus type 1 infection. FEBS Lett. 248:48-52.
19. Hoffman, A. D., B. Banapour, and J. A. Levy. 1985. Characterization of the AIDS-associated retrovirus reverse transcriptase and optimal conditions for its detection in virions. Virology 147:326-335.
20. Hollinger, F. B. (ed.). 1993. ACTG virology manual for HIV laboratories, p. Mac-1-Mac-4. Division of AIDS, National Institute of Allergy and Infectious Diseases. Bethesda, Md.
21. Johnson, V. A., and R. E. Byington. 1990. Quantitative assays for viral infectivity, p. 71-76. In A. Aldovini and B. D. Walker (ed.), Techniques in HIV research. Stockton Press, New York.
22. Klenk, H.-D., and W. Garten. 1994. Activation cleavage of viral spike proteins by host proteases, p. 241-280. In E. Wimmer (ed.), Cellular receptors for animal viruses. Cold Spring Harbor Laboratory Press, Plainview, N.Y.
23. Kliks, S. C., T. Shioda, N. L. Haigwood, and J. A. Levy. 1993. V3 variability can influence the ability of an antibody to neutralize or enhance infection by diverse strains of human immunodeficiency virus type 1. Proc. Natl. Acad. Sci. USA 90:11518-11522.
24. Koito, A., T. Hattori, T. Murakami, S. Matsushita, Y. Maeda, T. Yamamoto, and K. Takatsuki. 1989. A neutralizing epitope of human immunodeficiency virus type 1 has homologous amino acid sequences with the active site of inter-α-trypsin inhibitor. Int. Immunol. 1:611-617.
25. Koyanagi, Y., S. Miles, R. T. Mitsuyasu, J. E. Merrill, H. V. Vintners, and I. S. Y. Chen. 1987. Dual infection of the central nervous system by AIDS viruses with distinct cellular tropisms. Science 236:819-822.
26. Laemmli, U. K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature (London) 227:680-685.
27. Laman, J. D., M. M. Schellekens, G. K. Lewis, J. P. Moore, T. J. Matthews, J. P. Langedijk, R. H. Meloen, W. J. Boersma, and E. Claassen. 1993. A hidden region in the third variable domain of HIV-1 IIIB gp120 identified by a monoclonal antibody. AIDS Res. Hum. Retroviruses 9:605-612.
28. LaRosa, G. J., J. P. Davide, K. Weinhold, J. A. Waterbury, A. T. Profy, J. A. Lewis, A. J. Langlois, G. R. Dreesman, R. N. Boswell, P. Shadduck, L. H. Holley, M. Karpus, D. P. Bolognesi, T. J. Matthews, E. A. Emini, and S. D. Putney. 1990. Conserved sequence and structural elements in the HIV-1 principal neutralizing determinant. Science 249:932-935.
29. Manchanda, N., and B. S. Schwartz. 1990. Lipopolysaccharide-induced modulation of human monocyte urokinase production and activity. J. Immunol. 145:4174-4180.
30. Manchanda, N., and B. S. Schwartz. 1991. Single chain urokinase: augmentation of enzymatic activity upon binding to monocytes. J. Biol. Chem. 266:14580-14584.
31. McNeely, T. B., M. Dealy, D. J. Dripps, J. M. Orenstein, S. P. Eisenberg, and S. M. Wahl. 1995. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 96:456-464.
32. Moore, J. P., B. A. Jameson, R. A. Weiss, and Q. J. Sattentau. 1993. The HIV-cell fusion reaction, p. 234-289. In J. Bentz (ed.), Viral fusion mechanisms. CRC Press, Inc., Boca Raton, Fla.
33. Moore, J. P., Q. J. Sattentau, R. Wyatt, and J. Sodroski. 1994. Probing the structure of the human immunodeficiency virus surface glycoprotein gp120 with a panel of monoclonal antibodies. J. Virol. 68:469-484.
34. Murakami, T., T. Hattori, and K. Takatsuki. 1991. A principal neutralizing domain of human immunodeficiency virus type 1 interacts with proteinase-like molecule(s) at the surface of Molt-4 clone 8 cells. Biochim. Biophys. Acta 1079:279-284.
35. Myers, G., S. Korber, S. Wain-Hobson, K. T. Jeang, L. E. Henderson, and G. N. Pavlakis (ed.), Human retroviruses and AIDS 1994. Los Alamos National Laboratory, Los Alamos, N.Mex.
36. Nieva, J. L., S. Nir, A. Muga, F. M. Goni, and J. Wilschut. 1994. Interaction of the HIV-1 fusion peptide with phospholipid vesicles: different structural requirements for fusion and leakage. Biochemistry 33:3201-3209.
37. Nuovo, G. J. 1992. PCR in situ hybridization: protocols and applications. Raven Press, New York.
38. Ou, C. Y., S. Kwok, S. W. Mitchell, D. H. Mack, J. J. Sninsky, J. W. Krebs, P. Feorino, D. Warfield, and G. Schochetman. 1988. DNA amplification for direct detection of HIV-1 in DNA of peripheral blood mononuclear cells. Science 239:295-297.
39. Page, K. A., S. M. Stearns, and D. R. Liftman. 1992. Analysis of mutations in the V3 domain of gp160 that affect fusion and infectivity. J. Virol. 66:524-533.
40. Popovic, M., M. G. Sarngadharan, E. Read, and R. C. Gallo. 1984. Detection, isolation and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS. Science 224:497-500.
41. Scheiblauer, H., M. Reinacher, M. Tashiro, and R. Roll. 1992. Interactions between bacteria and influenza A virus in the development of influenza pneumonia. J. Infect. Dis. 166:783-791.
42. Schulz T. F., J. D. Reeves, J. G. Hoad, C. Tailor, P. Stephens, G. Clements, S. Ortlepp, K. A. Page, J. P. Moore, and R. A. Weiss. 1993. Effects of mutations in the V3 loop of HIV-1 gp120 on infectivity and susceptibility to protcolytic cleavage. AIDS Res. Hum. Retroviruses 9:159-166.
43. Skinner, M. A., A. J. Langlois, C. B. McDanal, J. S. McDougal, D. P. Bolognesi, and T. J. Matthews. 1988. Neutralizing antibodies to an immunodominant envelope sequence do not prevent gp120 binding to CD4. J. Virol. 62:4195-4200.
44. Sodeinde, O. A., Y. Subrahmanyam, K. Stark, T. Quan, Y. Bao, and J. D. Goguen. 1992. A surface protease and the invasive character of plague. Science 258:1004-1007.
45. Stephens, R. W., J. Pollanen, H. Tapiovaara, G. Woodrow, and A. Vaheri. 1991. Stimulation of cell surface plasminogen activation by heparin and related polyionic substances. Semin. Thromb. Hemostasis 17:201-209.
46. Suzuki, K., B. P. Craddock, N. Okamoto, T. Kano, and R. T. Steigbigel. 1993. Poly A-linked colorimetric microtiter plate assay for HIV reverse transcriptase. J. Virol. Methods 44:189-198.
47. Werner, A., and J. A. Levy. 1993. Human immunodeficiency virus type 1 envelope gp120 is cleaved after incubation with recombinant soluble CD4. J. Virol. 67:2566-2574.